Simplify Logo

Full-Time

Head of Process Development

Posted on 5/7/2024

Asimov

Asimov

51-200 employees

Integrated platform for genetic design and engineering

Biotechnology

Senior

Cambridge, MA, USA

Category
Bioinformatics
Computational Biology
Biology Lab & Research
Biology & Biotech
Requirements
  • Ph.D. in Chemical Engineering, Bioengineering, Biotechnology, or related field
  • 5+ years of management experience
  • 10+ years of upstream process development experience at a biopharma company or CDMO
  • Experience in CHO-based biologic or HEK293-based viral vector process development
  • Experience in GMP manufacturing principles or ISO9001
  • Highly organized and detail-oriented
Responsibilities
  • Lead CHO and HEK biotherapeutic upstream process development
  • Manage scientists in upstream process development activities
  • Guide team towards personal and professional development milestones
  • Employ hypothesis-driven experimental and process design
  • Collaborate with Modeling and Simulation team
  • Author, review, and approve study plans and reports
  • Drive technology development efforts
  • Attend and present at industry conferences
  • Contribute to industry forums
  • Support patent applications
  • Write manuscripts for publication

Asimov offers a conducive environment for professionals passionate about genetic engineering, providing an integrated platform that includes engineered host cells, a genetic parts library, and advanced cloud-based design software. The company excels in the biotechnology field with its expertise in rationally-designed vectors, transposase-mediated integration, and scalable production of viral vectors, positioning it as a leader in biologics and gene therapies development. This focus on cutting-edge technology and substantial industry contributions makes it an ideal workplace for innovation-driven individuals.

Company Stage

Series B

Total Funding

$204.7M

Headquarters

Boston, Massachusetts

Founded

2017

Growth & Insights
Headcount

6 month growth

2%

1 year growth

19%

2 year growth

82%
INACTIVE